the aid library

LIST OPTIONS

Filter

10570

Download (351)

View PDF (490)

Community Ear & Hearing Health - Volume 9 • Issue 12 (2012)

Community Ear & Hearing Health (2012) C2

This journal is funded by CBM

Download (346)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (266)

View PDF (271)

Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men
recommended

World Health Organization WHO (2018) C_WHO

Download (578)

View PDF (978)

Tanzania: HIV Care and Treatment Plan 2003-2008

The William J. Clinton Foundation Ministry of Health, Tanzania (2003) C1

Download (342)

View PDF (816)

India’s Disability Policy – Analysis of Core Concepts of Human Rights

Jessica O’Dowd, Hasheem Mannan, Joanne McVeigh (2013) C1

Download (403)

View PDF (725)

Namibia Health Facility Census 2009: Key Findings on Family Planning, Maternal and Child Health, and Malaria

Ministry of Health and Social Services (MoHSS), Namibia; ICF Macro, USA (2010) C_WHO

Download (342)

View PDF (701)

The role of an essential health benefit in the delivery of integrated health services: Learning from practic e in East and Southern Africa

Regional Network for Equity in Health in East and Southern Africa (EQUINET) (2018) C1

Download (574)

View PDF (1181)

International technical guidance on sexuality education. An evidence-informed approach.

UNESCO (2018) CC

This revised and fully updated edition of the International technical guidance on sexuality education benefits from a new review of the current evidence, and reaffirms the position of sexuality education within a framework of human rights and gender equality. It promotes structured learning about... more

Download (449)

View PDF (617)

Green Climate Fund Proposal Toolkit 2017: Toolkit to develop a project proposal for the GCF

Fayolle, Virginie; Odianose, Serena Acclimatise, Climate and Development Knowledge Network (CDKN) (2017) C1

The GCF aims to support developing countries in achieving a paradigm shift to low-emission and climate-resilient pathways. This is achieved by funding innovative and transformative lowemission (mitigation) and climate-resilient (adaptation) projects and programmes developed by the public and private... more

Download (314)

View PDF (465)

Brochure: Ear and Hearing Care & Education of persons who are deaf, hard of hearing or deafblind

Christoffel Blinden Mission (CBM) Christoffel Blinden Mission (CBM) (2015)

Download (264)

View PDF (639)

Relevance of CBR and Inclusive Development in Post 2015 Agenda

Thomas, M. and Ninomiya, A. CBR Asia-Pacific Network (2015) C1

Download (496)

View PDF (1146)

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO) (2018) C_WHO

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t... more

Download (321)

View PDF (352)

Fostering Public-Private Partnerships to Improve Access to Family Planning in Rwanda

Pandit-Rajani, T., S. Sharma, and F. Muramutsa. USAID (2010) C2

Through public-private partnerships, the government of Rwanda can make more efficient use of public resources by targeting and meeting the needs of specific populations and thus help ensure family planning services and products will be available to all Rwandans in the long term. This report aims to ... more

Download (465)

View PDF (663)

National Disaster Management Guidelines. Management of Floods

Government of India, National Disaster Management Authority (2008) C1

The guidelines are presented in the form of the following chapters:
Chapter 1: Floods status and context
Chapter 2: Institutional framework and financial arrangements
Chapter 3: Flood prevention, preparedness and mitigation
Chapter 4: Flood forecasting and warning in India
C... more

Download (581)

View PDF (1266)

Vision 2030 Development Strategy for Northern Kenya and other Arid Lands

Government of Kenya (2012) C1

Download (185)

View PDF (299)

Methamphetamine continues to dominate synthetic drug markets

United Nations Office on Drugs and Crime; Global smart (2018) C2

Volume 20, September Global smart update

Download (312)

View PDF (369)

Key political commitment documents for tuberculosis prevention and care and their intended influence in the WHO European Region

World Health Organization WHO, Regional Office for Europe (2019) C_WHO

This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international... more

Download (389)

View PDF (593)

Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization WHO (2018) C_WHO

The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I... more

Download (539)

View PDF (489)

Better Parenting Curriculum Nigeria: Community Discussion Guide

Catholic Relief Services CRS; 4Children; InHealth, et al. (2018) C1

ts goals are to ensure that: Children and parents experience fewer conflicts; Parents make better decisions about the care of their children and are better able to solve problems; and Children feel more supported by their families to further their education and make good decisions a... more

Download (788)

View PDF (629)

Child Protection Case Management Operations Manual

Catholic Relief Services CRS; 4Children (2018) C1

Case management is an approach at the core of social work. Case management is the process required for improving the quality of life for vulnerable children in need of care and protection. This manual is intended to support social workers in their case management role and reduce overall workload by ... more

Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men recommended

Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men
recommended